Renalytix plc Payments to Acquire in Process Research and Development
Renalytix plc (RENXF) reported Payments to Acquire in Process Research and Development of $11.02 million for the 12-month period ending 2019-06-30, per its 20-F/A filed 2022-08-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2022-08-01
| Period end | Payments to Acquire in Process Research and Development 12 month |
|---|---|
| 2019-06-30 | $11.02M 20-F/A · filed 2022-08-01 |